Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment

References

• Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association council for high blood pressure research professional education committee, Council on clinical cardiology, Stroke council, and Council on cardiovascular nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation118(10), 1080–1111 (2008).
   PubMed Web of Science ®Google Scholar
• Giustina A, Casanueva FF, Cavagnini F et al. Consensus: diagnosis and treatment of acromegaly complications. J. Endocrinol. Invest.26(12), 1242–1247 (2003).
   PubMed Web of Science ®Google Scholar
• Colao A, Pivonello R, Mazzullo P et al. Severe systemic complications of acromegaly. J. Endocrinol. Invest.28(Suppl.5), 65–77 (2005).
   PubMedGoogle Scholar
• Martin JM, Carrizo SJ, Vincente E, Agust AG. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet365, 1046–1053 (2005).
   PubMedGoogle Scholar
• Yaggi HK, Concato JK, Kerman WN et al. Obstructive sleep apnoea as a risk factor for stroke and death. N. Engl. J. Med.353, 2034–2041 (2005).
   PubMed Web of Science ®Google Scholar
• Perks WH, Horrocks PM, Cooper RA et al. Sleep apnoea in acromegaly. Br. Med. J.280(6218), 894–897 (1980).
   PubMedGoogle Scholar
• Hart TB, Radow SK, Blackard WG et al. Sleep apnoea in active acromegaly. Arch. Intern. Med.145(5), 865–866 (1985).
   PubMedGoogle Scholar
• Lindberg E, Carter N, Gislason T, Janson C. Role of snoring and daytime sleepiness in occupational accidents. Am. J. Respir. Crit. Care Med.164, 2031–2035 (2001).
   PubMed Web of Science ®Google Scholar
• Epstein LJ, Kristo D, Strollo PJ et al.; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J. Clin. Sleep Med.5(3), 263–276 (2009).
   PubMed Web of Science ®Google Scholar
• Davì MV, Dalle Carbonare L, Giustina A et al. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur. J. Endocrinol.159, 533–540 (2008).
   PubMed Web of Science ®Google Scholar
• Pekkarinen T, Partinen M, Pelkonen R et al. Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clin. Endocrinol. (Oxf.)27(6), 649–654 (1987).
   PubMed Web of Science ®Google Scholar
• Pelttari L, Polo O, Rauhala E et al. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin. Endocrinol. (Oxf.)43(2), 175–182 (1995).
   PubMed Web of Science ®Google Scholar
• Rosenow F, Reuter S, Deuss U et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin. Endocrinol. (Oxf.)45(5), 563–569 (1996).
   PubMed Web of Science ®Google Scholar
• Saeki N, Isono S, Nishino T et al. Sleep-disordered breathing in acromegalics-relation of hormonal levels and quantative sleep study by means of bedside oximeter. Endocr. J.46(4), 585–590 (1999).
   PubMedGoogle Scholar
• Tolis G, Angelopoulos NG, Katounda E et al. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology83, 249–257 (2006).
   PubMedGoogle Scholar
• Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J. Clin. Endocrinol. Metab.95, 483–495, (2010).
   PubMed Web of Science ®Google Scholar
• Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann. Intern. Med.115, 527–532 (1991).
   PubMed Web of Science ®Google Scholar
• Fatti LM, Sacchi M, Pincelli AI et al. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary4(4), 259–262 (2001).
   PubMedGoogle Scholar
• Weiss V, Sonka K, Pretl M et al. Prevalence of the sleep apnea syndrome in acromegaly population. J. Endocrinol. Invest.23, 515–519 (2000).
   PubMed Web of Science ®Google Scholar
• Hochban W, Ehlenz K, Conradt R, Brandenburg U. Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur. Respir. J.14(1), 196–202 (1999).
   PubMed Web of Science ®Google Scholar
• Sze L, Schmid C, Bloch KE et al. Effect of transsphenoidal surgery on sleep apnea in acromegaly. Eur. J. Endocrinol.156, 321–329 (2007).
   PubMed Web of Science ®Google Scholar
• Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep20, 705–706 (1997).
   PubMed Web of Science ®Google Scholar
• Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med.165, 1217–1239 (2002).
   PubMed Web of Science ®Google Scholar
• Bixler EO, Vgontzas AN, Ten Have T et al. Effects of age on sleep apnea in men: I: prevalence and severity. Am. J. Respir. Crit. Care Med.157, 144–148 (1998).
   PubMed Web of Science ®Google Scholar
• De Menis E, Giustina A, Colao A et al. COM.E.T.A. Italian study group. Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian study group. J. Endocrinol Invest.34(1), 60–64 (2011). Erratum in: J. Endocrinol. Invest.34(2), 169 (2011).
   PubMed Web of Science ®Google Scholar
• Kamenicky P, Viengchareun S, Blanchard A et al. Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology149, 3294–3305 (2008).
   PubMed Web of Science ®Google Scholar
• Dostalova S, Sonka K, Smahel Z et al. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur. J. Endocrinol.144(5), 491–497 (2001).
   PubMedGoogle Scholar
• Van Haute FR, Taboada GF, Corrêa LL et al. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur. J. Endocrinol.158, 459–465 (2008).
   PubMed Web of Science ®Google Scholar
• Berg C, Wessendorf TE, Mortsch F et al. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur. J. Endocrinol.161(6), 829–835 (2009).
   PubMedGoogle Scholar
• Ip MSM, Tan KCB, Peh WCG, Lam KSL. Effects of sandostatin lar on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin. Endocrinol.55, 477–483 (2001).
   PubMed Web of Science ®Google Scholar
• Isono S, Saeki N, Tanaka A, Nishino T. Collapsibility of passive pharynx in patients with acromegaly. Am. J. Respir. Crit. Care Med.160(1), 64–68 (1999).
   PubMed Web of Science ®Google Scholar
• Herrmann BL, Wessendorf TE, Ajaj W et al. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur. J. Endocrinol.151(3), 309–315 (2004).
   PubMed Web of Science ®Google Scholar
• Shelton KE, Woodson H, Gay S, Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am. Rev. Respir. Dis.148, 462–466 (1993).
   PubMedGoogle Scholar
• Horner RL, Mohiaddin RH, Lowell DG et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur. Respir. J.2, 613–622 (1989).
   PubMed Web of Science ®Google Scholar
• Grunstein RR, Handelsman DJ, Lawrence SJ et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J. Clin. Endocrinol. Metab.68, 352–358 (1989).
   PubMed Web of Science ®Google Scholar
• Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol. Metab. Clin. North Am.37(1), 67–99 (2008).
   PubMed Web of Science ®Google Scholar
• Grynberg M, Salenave S, Young J, Chanson P. Female gonadal function before and after treatment of acromegaly. Clin. Endocrinol. Metab.95(10), 4518–4525 (2010).
   Google Scholar
• Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol.99(5), 1998–2007 (2005).
   PubMed Web of Science ®Google Scholar
• Rasche K, Keller T, Tautz B et al. Obstructive sleep apnea and Type 2 diabetes. Eur. J. Med. Res.15(Suppl. 2), S152–S156 (2010).
   PubMedGoogle Scholar
• Adams N, Strauss M, Schluchter M et al. Relation of measures of sleep-disordered breathing to neuropsychological functioning. Am. J. Respir. Crit. Care Med.163, 1626–1631 (2001).
   PubMed Web of Science ®Google Scholar
• Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet365(9464), 1046–1053 (2005).
   PubMed Web of Science ®Google Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep14, 540–545 (1991).
   PubMed Web of Science ®Google Scholar
• Melmed S, Colao A, Barkan A et al. Guidelines for acromegaly management: an update J. Clin. Endocrinol. Metab.94, 1509–1517 (2009).
   PubMed Web of Science ®Google Scholar
• Giustina A, Chanson P, Bronstein MD et al. A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab.95, 3141–3148 (2010).
   PubMed Web of Science ®Google Scholar
• Gola M, Bonadonna S, Mazziotti G et al. Resistance to somatostatin analogs in acromegaly: an evolving concept? J. Endocrinol. Invest.29(1), 86–93 (2006).
   PubMed Web of Science ®Google Scholar
• Pokrajac A, Wark G, Ellis AR et al. Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice. Clin. Endocrinol. (Oxf.)67(1), 65–70 (2007).
   PubMed Web of Science ®Google Scholar
• Mickelson SA, Rosenthal LD, Rock JP et al. Obstructive sleep apnea syndrome and acromegaly. Otolaryngol. Head Neck Surg. J.111(1), 25–30 (1994).
   PubMedGoogle Scholar
• Main G, Borsey DQ, Newton RW. Successful reversal of sleep apnoea syndrome following treatment for acromegaly, confirmed by polygraphic studies. Postgrad. Med. J.64(758), 945–946 (1988).
   PubMedGoogle Scholar
• Piper JG, Dirks BA, Traynelis VC, VanGilder JC. Perioperative management and surgical outcome of the acromegalic patient with sleep apnea. Neurosurgery36(1), 70–74; Discussion 74–75 (1995).
   PubMed Web of Science ®Google Scholar
• Chanson P, Timsit J, Benoit O et al. Rapid improvement in sleep apnoea of acromegaly after short-term treatment with somatostatin analogue SMS 201–995. Lancet1, 1270–1271 (1986).
   PubMed Web of Science ®Google Scholar
• Leibowitz G, Shapiro MS, Salameh M, Glaser B. Improvement of sleep apnoea due to acromegaly during short-term treatment with octreotide. J. Intern. Med.236, 231–235 (1994).
   PubMedGoogle Scholar
• Liao P, Yegneswaran B, Vairavanathan S et al. Postoperative complications in patients with obstructive sleep apnea: a retrospective matched cohort study. Can. J. Anaesth.56(11), 819–828 (2009).
   PubMed Web of Science ®Google Scholar
• Buyse B, Michiels E, Bouillon R et al. Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature. Eur. Respir. J.10(6), 1401–1404 (1997).
   PubMedGoogle Scholar
• Grunstein RR, Ho KK, Sullivan CE. Effect of octreotide, a somtatostatin analog, on sleep apnea in patients with acromegaly. Ann. Inter. Med.121(7), 478–483 (1994).
   PubMed Web of Science ®Google Scholar
• Grunstein RR, Ho KY, Berthon-Jones M et al. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am. J. Respir. Crit. Care Med.150(2), 496–502 (1994).
   PubMed Web of Science ®Google Scholar
• Melmed S, Casanueva F, Cavagnini F et al. Consensus statement: medical management of acromegaly. Eur. J. Endocrinol.153(6), 737–740 (2005).
   PubMed Web of Science ®Google Scholar
• Giustina A, Bronstein MD, Casanueva FF et al. Current management practices for acromegaly: an international survey. Pituitary14(2), 125–133 (2011).
   PubMed Web of Science ®Google Scholar
• Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation107, 68–73 (2003).
   PubMed Web of Science ®Google Scholar
• Harbison J, O’Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest118, 591–595 (2000).
   PubMed Web of Science ®Google Scholar
• Fleetham J, Ayas N, Bradley D et al. Sleep disordered breathing committee. Canadian thoracic society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can. Respir. J.13(7), 387–392 (2006).
   PubMedGoogle Scholar
• Maison P, Tropeano AI, Macquin-Mavier I et al. Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. Clin. Endocrinol. Metab.92(5), 1743–1747 (2007).
   Google Scholar